Yuting Zhan
Changsha, 410011, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
Itraconazole Reversing Acquired Resistance to Osimertinib in NSCLC by Inhibiting the SHH/DUSP13B/p-STAT3 Axis.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 13, 2024
Unveiling immune resistance mechanisms in nasopharyngeal carcinoma and emerging targets for antitumor immune response: tertiary lymphoid structures.
Journal: Journal of translational medicine
Published: July 31, 2024
Targeting EGFR-binding protein SLC7A11 enhancing antitumor immunity of T cells via inducing MHC-I antigen presentation in nasopharyngeal carcinoma.
Journal: Cell death & disease
Published: May 16, 2024
Somatostatin receptor2 (SSTR2) expression, prognostic implications, modifications and potential therapeutic strategies associates with head and neck squamous cell carcinomas.
Journal: Critical reviews in oncology/hematology
Published: September 03, 2023
SSTR2 positively associates with EGFR and predicts poor prognosis in nasopharyngeal carcinoma.
Journal: Journal of clinical pathology
Published: May 29, 2023
G3BP1 Interact with JAK2 mRNA to Promote the Malignant Progression of Nasopharyngeal Carcinoma via Activating JAK2/STAT3 Signaling Pathway.
Journal: International journal of biological sciences
Published: April 16, 2023
Role of β-catenin in PD-L1 expression of nasopharyngeal carcinoma.
Journal: Heliyon
Published: January 21, 2023
YAP1 synergize with YY1 transcriptional co-repress DUSP1 to induce osimertinib resistant by activating the EGFR/MAPK pathway and abrogating autophagy in non-small cell lung cancer.
Journal: International journal of biological sciences
Published: October 17, 2022
Seroprevalence of antibodies to classical swine fever virus and porcine reproductive and respiratory syndrome virus in healthy pigs in Hunan Province, China.
Journal: Polish journal of veterinary sciences
Published: September 26, 2022
BRD7 inhibits enhancer activity and expression of BIRC2 to suppress tumor growth and metastasis in nasopharyngeal carcinoma.
Journal: Cell death & disease
Published: August 22, 2022
Last Updated: 09/26/2026